NCT03075878 - A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

April 15, 2019

Study Completion Date

August 6, 2019

Conditions

Warm Autoimmune Hemolytic Anemia

Interventions

DRUG

ALXN1830

Administered via IV infusion.

Trial Locations (10)

Alexion Study Site, Amman

Alexion Study Site, Pittsburgh

Alexion Study Site, Philadelphia

Alexion Study Site, Cleveland

Alexion Study Site, Rochester

Alexion Study Site, Los Angeles

Alexion Study Site, San Francisco

Alexion Study Site, Seattle

Alexion Study Site, Boston

Alexion Study Site, Pittsfield